Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

ITI Pharma and Healthcare Fund · Direct ✕Franklin Asian Equity Fund · Direct ✕

Growth of ₹10,000

Basics

ITI Pharma and Healthcare FundFranklin Asian Equity Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseITIFranklin
NAV₹20.7004₹45.3436
NAV date20 Nov 202619 Nov 2026
History5.0 years13.9 years
Expense ratio0.9%1.2%
Stars★★★★★★★★★★
Growth Score72.8065.10

Returns

ITI Pharma and Healthcare FundFranklin Asian Equity Fund
1 month+11.35%−1.78%
3 months+4.42%−8.66%
6 months+12.33%−3.66%
YTD+21.31%+16.21%
1 year+18.01%+20.98%
3 years (CAGR)+19.94%+19.44%
5 years (CAGR)+15.73%+6.81%
10 years (CAGR)—+10.32%
Since launch+15.56%+9.32%

Risk

ITI Pharma and Healthcare FundFranklin Asian Equity Fund
Volatility15.9%17.7%
Downside volatility10.1%10.4%
Sharpe0.850.73
Sortino1.341.25
Calmar1.171.37
Return / risk1.251.10
Deepest fall−17.69%−40.20%
Days to recover3641074
Below its high+0.00%−11.70%

Against benchmark

ITI Pharma and Healthcare FundFranklin Asian Equity Fund
Alpha−1.30%+10.56%
Beta0.980.51
R²84.6%21.3%
Up capture94.1%69.9%
Down capture98.8%1.9%
Tracking error6.2%17.6%
Information ratio−0.260.45
Treynor0.130.26

Consistency

ITI Pharma and Healthcare FundFranklin Asian Equity Fund
Best 1-year+61.91%+71.57%
Middle 1-year+15.57%+10.63%
Worst 1-year−9.32%−32.93%
1-year periods with a loss21.7%26.1%
Middle 3-year+21.36%+8.99%
Positive months72.2%58.3%
Best day+3.48%+5.04%
Worst day−3.28%−6.66%
Worst 5% day−1.48%−1.67%
Positive days56.0%56.9%
NAVs a year247247

SIP of ₹10,000 a month

ITI Pharma and Healthcare FundFranklin Asian Equity Fund
5-year XIRR—+15.08%
5-year value—₹8,81,338
3-year XIRR+15.60%+19.77%
1-year XIRR+27.81%+4.81%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth